EPA Triggers Emerging Viral Pathogens Policy for Marburg Virus

In response to recent simultaneous outbreaks of Marburg virus in Tanzania and Equatorial Guinea the United States EPA has engaged the Emerging viral Pathogens Policy (EVP). The Ministry of Health and Social Welfare for Equatorial Guinea first announced the outbreak on February 7, 2023. Since the announcement, 15 cases and 11 deaths have been confirmed [...]

Interim Guidance for Products Including or Adding Efficacy Claims for Use on Porous Materials in Non-Residential Settings

On December 21, 2022, EPA published an Interim Guidance and two new methods to add bacterial and viral disinfection claims on porous surfaces.  The guidance and methods may be used immediately for claim support, though registrants should be aware that EPA released the guidance with a 30-day comment period that was then extended through February [...]

2023-01-19T15:37:27+00:00EPA, Test Management|

SRC Summary of Changes in EPA Guidance for Products Adding Residual Efficacy Claims

On October 7th, EPA released its new Guidance for Products Adding Residual Efficacy Claims. After a thorough review including a comparative review of historical documents and all linked methods, and the Response to Comments document, Scientific & Regulatory Consultants, Inc. (SRC) has created the below summary of changes. Registrants are being given a 1-year implementation [...]

EPA Triggers Emerging Viral Pathogens Policy for Ebola Virus

Due to the ongoing Ebola outbreak in Uganda, the United States EPA has engaged its Emerging viral Pathogens Policy (EVP). The current outbreak of Ebola Virus Disease is caused by infection with Sudan ebolavirus. The first confirmed case was identified in a 25-year-old male in the Mubende District of Uganda on September 19th; though it [...]

810 Guidelines FAQ Document (8-28-19) Summary

On August 28, 2019, the 2018 810 guidelines for 810.2000 General Considerations, 810.2100 Sporicidal Testing, and 810.2200 Disinfectant Testing were implemented with a new "Series 810 Guidelines FAQ" guidance. All efficacy testing must now comply with these documents though EPA will continue to accept studies conducted under the 2012 guidelines where the protocol was signed [...]

2020-03-13T18:06:01+00:00Test Management|